Abstract:Introduction: Outcomes in type 2 diabetes mellitus (T2DM) could be optimized by identifying which treatments are likely to produce the greatest improvements in glycemic control for each patient. Objectives: We aimed to identify patient characteristics associated with achieving and maintaining a target glycated hemoglobin (HbA1c) of ≤ 7% using machine learning methodology to analyze clinical trial data on combination therapy for T2DM. By applying a new machine learning methodology to an existing clinical dataset, the practical application of this approach was evaluated and the potential utility of this new approach to clinical decision making was assessed. Methods: Data were pooled from two phase III, randomized, double-blind, parallel-group studies of empagliflozin/linagliptin single-pill combination therapy versus each monotherapy in patients who were treatment-naïve or receiving background metformin. Descriptive analysis was used to assess univariate associations between HbA1c target categories and each baseline characteristic. After the descriptive analysis results, a machine learning analysis was performed (classification tree and random forest methods) to estimate and predict target categories based on patient characteristics at baseline, without a priori selection. Results: In the descriptive analysis, lower mean baseline HbA1c and fasting plasma glucose (FPG) were both associated with achieving and maintaining the HbA1c target. The machine learning analysis also identified HbA1c and FPG as the strongest predictors of attaining glycemic control. In contrast, covariates including body weight, waist circumference, blood pressure, or other variables did not contribute to the outcome. Conclusions: Using both traditional and novel data analysis methodologies, this study identified baseline glycemic status as the strongest predictor of target glycemic control attainment. Machine learning algorithms provide an hypothesis-free, unbiased methodology, which can greatly enhance the search for predictors of therapeutic success in T2DM. The approach used in the present analysis provides an example of how a machine learning algorithm can be applied to a clinical dataset and used to develop predictions that can facilitate clinical decision making.

Review: Machine Learning in Precision Pharmacotherapy of Type 2 Diabetes—a Promising Future or a Glimpse of Hope?

Artificial intelligence and machine learning in diabetes research

Recent progress in artificial intelligence and machine learning for novel diabetes mellitus medications development

Machine learning in precision diabetes care and cardiovascular risk prediction

Application of Machine Learning Methods for the Development of Antidiabetic Drugs

Machine Learning to Identify Predictors of Glycemic Control in Type 2 Diabetes: An Analysis of Target HbA1c Reduction Using Empagliflozin/Linagliptin Data

Machine learning and deep learning predictive models for type 2 diabetes: a systematic review

Research on Diabetes Prediction Based on Machine Learning

Application of Machine Learning in the Field of Diabetes

A review on artificial intelligence and machine learning used in pharmaceutical research

Machine Learning and Artificial Intelligence in Pharmaceutical Research and Development: a Review

Precision Medicine in Type 2 Diabetes: Using Individualized Prediction Models to Optimize Selection of Treatment

Predicting Antidiabetic Peptide Activity: A Machine Learning Perspective on Type 1 and Type 2 Diabetes

Computational approaches for clinical, genomic and proteomic markers of response to glucagon-like peptide-1 therapy in type-2 diabetes mellitus: An exploratory analysis with machine learning algorithms

A comprehensive review of machine learning techniques on diabetes detection

Machine Learning Approaches for Type 2 Diabetes Prediction and Care Management

Advances in Precision Medicine Approaches for Type 2 Diabetes Management: A Comprehensive Review

A Comprehensive Survey on Diabetes Type-2 (T2D) Forecast Using Machine Learning

Application of machine learning in affordable and accessible insulin management for type 1 and 2 diabetes: A comprehensive review

Artificial Intelligence-Based Methods for Precision Medicine: Diabetes Risk Prediction

Artificial Intelligence in Current Diabetes Management and Prediction